For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has ...
Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...
Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first precision medicine combo for patients with BRCA2-mutated metasta | Akeega, a ...
Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped around the urethra, as seen in this image taken from Asklepios Atlas of ...
Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.
TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...
Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.
PC SPES is a over the counter dietary supplement that is becoming very popular among men with prostate cancer. (Photo by Glenn Koenig/Los Angeles Times via Getty Images) (Update: please see the ...
Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...
Prostate cancer and an enlarged prostate are not the same thing. (Getty Images) On Yahoo Search, searches around terms including "prostate cancer" have gone up about 150% since the royal's diagnosis ...
Cancer of the prostate has become the leading cause of cancer diagnoses among males in the United Kingdom. Its treatment, ...
Nigeria records over 18,000 new prostate cancer cases annually, accounting for the highest cancer burden among men in the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results